Re: CAR T Cells: Off the Shelf and On the Mark
Here is a question for you.
We have heard about Sleeping Beauty's robust proliferation rates in the body.
In stem cell vectoring, do you have any idea about the initial dosing and relative proliferation rates?
I ask this because of my listen to a March '21 of a FATE R&D conference. They use iPSC and I concluded that they were planning multiple doses, separate by several weeks, of their iPSC therapies in order to obtain meaningful responses.
Tough question, TIA.